Takeda Pharmaceutical Company Limited - Company & Market Research Reports

Home /
Companies /
Takeda Pharmaceutical Company Limited

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 207
Endocrine and Metabolic Disorders Drugs 164
Central Nervous System Drugs 153
Gastrointestinal Drugs 148
Immune Disorders Drugs 139
Drug Discovery 117
Clinical Trials 95
Biopharmaceuticals 94
Pharmaceuticals 83
Hematological Drugs 74
Vaccines 74
Infectious Diseases Drugs 72
Cardiovascular Drugs 61
Diabetes Drugs 53
Leukemia Drugs 53
Mental Disorders Drugs 47
Musculoskeletal Disorders Drugs 43
Lymphoma Drugs 39
Infusions and Injectables 36
Over the Counter (OTC) Drugs 33
Liver and Kidney Disorders Drugs 31
Pharmaceutical Manufacturing 25
Lung Cancer Drugs 24
Sexual and Reproductive Health Drugs 24
Respiratory Drugs 22
Drug Delivery 20
Drugs by Therapeutic Area 15
Prostate Cancer Drugs 15
Antibiotics 15
Pharmaceutical Intermediates 14
Analgesics 14
Skin Cancer Drugs 12
Schizophrenia Drugs 11
Anti-Obesity Drugs 10
Alzheimer's Disease Drugs 9
Immunosuppressive Drugs 9
Addiction Disorders Drugs 8
Optical Disorders Drugs 8
Uterine Cancer Drugs 8
Colon Cancer Drugs 7
Biosimilars and Biosuperiors 7
Generic Drugs 6
Psoriasis Drugs 6
Brain Cancer Drugs 5
Thyroid Cancer Drugs 5
Dermatological Drugs 5
Urological Disorders Drugs 5
Liver Cancer Drugs 4
Breast Cancer Drugs 4
Cervical Cancer Drugs 4
Company Reports 3
Animal Pharmaceuticals 3
Pharmacoeconomics 3
Transdermal and Transmucosal Drug Delivery 3
Kidney Cancer Drugs 3
Ovarian Cancer Drugs 2
Anesthetic Drugs 2
Cancer Vaccines 2
Pancreatic Cancer Drugs 2
Vitamins and Dietary Supplements 2
HIV/AIDS Drugs 2
Bladder Cancer Drugs 1
Cough and Cold Drugs 1
Inhalers and Nebulisers 1
Anxiety Drugs 1
Asthma Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



273 reviews

1,746 Results (Page 33 of 88)
- Relevance
  Sort by

Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
295 Pages
Global

From

€2205EUR$2,500USD£1,902GBP

Antibody Drug Conjugate Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
118 Pages
Global

From

€3969EUR$4,500USD£3,423GBP

Atypical Teratoid Rhabdoid Tumors (ATRT)- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1102EUR$1,250USD£951GBP

Proteasome Inhibitors Market Report and Forecast 2024-2032

 Report
November 2023
198 Pages
Global

From

€3174EUR$3,599USD£2,738GBP

Immunology Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

 Report
February 2024
100 Pages
Global

From

€3500EUR$4,251USD£3,125GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Hunter Syndrome Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
110 Pages
Global

From

€4189EUR$4,750USD£3,613GBP

Melanin Concentrating Hormone Receptor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
74 Pages
Global

From

€3500EUR$4,251USD£3,125GBP

Crohn's Disease Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, and Product Type

 Report
January 2024
87 Pages
Global

From

€3500EUR$4,251USD£3,125GBP

Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1588 Pages
Global

From

€2205EUR$2,500USD£1,902GBP

Thyroid Gland Disorders Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

 Report
September 2021
99 Pages
Global

From

€3969EUR$4,500USD£3,423GBP

Antidiabetic SGLT-2 Inhibitor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
September 2024
96 Pages
Global

From

€3500EUR$4,251USD£3,125GBP

Antidiabetic Biguanides Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
September 2024
98 Pages
Global

From

€3500EUR$4,251USD£3,125GBP

Allogeneic T Cell Therapies Market Report and Forecast 2024-2032

 Report
September 2023
160 Pages
Global

From

€3174EUR$3,599USD£2,738GBP

Antibody Drug Conjugates Market Report and Forecast 2024-2032

 Report
September 2023
140 Pages
Global

From

€3174EUR$3,599USD£2,738GBP

Autoimmune Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
141 Pages
Global

From

€3500EUR$4,251USD£3,125GBP

Blood Disorder Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
January 2022
115 Pages
Global

From

€4189EUR$4,750USD£3,613GBP

The Corporate Reputation of Pharma in 2022 - The Patient Perspective - Neurology Edition: The Views of 258 Neurology Patient Groups

 Report
November 2022
54 Pages
Global

€6750EUR$7,921USD£5,625GBP

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Autoimmune Edition - The Views of 293 Patient Groups (138 of these respondent patient groups specialised in arthritis)

 Report
November 2022
57 Pages
Global

€9599EUR$11,266USD£8,000GBP

Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
643 Pages
Global

From

€2205EUR$2,500USD£1,902GBP

Systemic Psoriasis Therapeutics - Global Strategic Business Report

 Report
July 2025
192 Pages
Global

From

€5159EUR$5,850USD£4,450GBP

1,746 Results (Page 33 of 88)
- 1
- 31
- 32
- 33
- 34
- 35

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.